Additional Information
Book Details
Abstract
Prepared by an author of international renown, Scully’s Handbook of Medical Problems in Dentistry offers a wealth of information in a handy easy-to-carry format. Containing over 250 colour photographs, artworks and tables, many of which have never been published before, this useful guide covers the main conditions seen in clinical practice together with their relevance to oral health care.
- Highlights the main points of human diseases and their relevance to oral healthcare in a practical way
- Gives particular focus on areas that are of major concern to dentistry and oral healthcare e.g. allergies, bleeding tendencies, endocrine disorders - especially diabetes - gravid patients, hepatitis and other transmissible diseases, and malignant disease
- Explains the process of risk assessment, pain and anxiety control, patient access and positioning, treatment modification and drug use
- ‘Relevance for Dentistry’ boxes highlight the most crucial aspects of specific conditions
- Contains new national and international guidelines, further reading and up-to-date websites
- More than meets the needs of the UK General Dental Council (GDC) document ‘Preparing for practice; Dental team learning outcomes for registration’.
- Ideal for all dental students, general dental practitioners and hospital-based dentists together with other oral healthcare staff who need to keep up to date with medical knowledge
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | cover | ||
| Handbook of Medical Problems in Dentistry | i | ||
| Copyright Page | iv | ||
| Table Of Contents | v | ||
| Preface | ix | ||
| 1 Health | 1 | ||
| Health hazards | 1 | ||
| Health promotion | 1 | ||
| Exercise | 1 | ||
| Healthy diet | 2 | ||
| Chemical avoidance | 2 | ||
| Further reading | 3 | ||
| 2 Healthcare | 5 | ||
| Medical history | 5 | ||
| Preoperative risk assessment | 5 | ||
| Preoperative planning | 7 | ||
| Pre-treatment issues | 7 | ||
| At treatment | 8 | ||
| Post-treatment | 9 | ||
| Consent | 11 | ||
| Culture | 12 | ||
| Communication with other care providers | 13 | ||
| Summary: comments that apply to the rest of this book | 13 | ||
| 3 Main emergencies | 15 | ||
| Emergency procedure | 17 | ||
| The ‘ABCDE’ approach to the sick patient | 18 | ||
| The patient brought in with an emergency | 18 | ||
| An emergency in the dental setting | 19 | ||
| First steps | 19 | ||
| Airway (A) | 19 | ||
| Breathing (B) | 20 | ||
| Circulation (C) | 20 | ||
| Disability (D) | 21 | ||
| Exposure (E) | 22 | ||
| Cardiopulmonary resuscitation (CPR) | 22 | ||
| Management of the more common emergencies in dentistry | 22 | ||
| Anaphylaxis (see also Section 5) | 22 | ||
| Symptoms and signs | 23 | ||
| Treatment | 23 | ||
| Angina (see also Section 5) | 24 | ||
| Symptoms and signs | 24 | ||
| Treatment | 24 | ||
| Asthma (see also Section 5) | 25 | ||
| Symptoms and signs | 25 | ||
| Treatment | 25 | ||
| Choking (Foreign body respiratory obstruction) | 25 | ||
| Collapse (see also Section 5) | 26 | ||
| Epileptic seizure (see also Section 5) | 27 | ||
| Symptoms and signs of a tonic-clonic (grand mal) seizure | 27 | ||
| Treatment | 27 | ||
| Faint | 28 | ||
| 4 Age and gender | 35 | ||
| Children | 35 | ||
| Premature babies | 35 | ||
| Neonates | 35 | ||
| Infants | 35 | ||
| Child from 1 year (pre-school child) | 36 | ||
| Child aged 5–12 years (schoolchild) | 36 | ||
| Puberty | 36 | ||
| Adolescence | 36 | ||
| Main dental considerations | 36 | ||
| Men’s health | 39 | ||
| Main dental considerations | 39 | ||
| Bladder cancer | 39 | ||
| Definition | 39 | ||
| Aetiopathogenesis | 39 | ||
| Clinical presentation and classification | 40 | ||
| Diagnosis | 40 | ||
| Treatment | 40 | ||
| Prostate cancer | 40 | ||
| Definition | 40 | ||
| Aetiopathogenesis | 40 | ||
| Clinical presentation | 40 | ||
| Diagnosis | 41 | ||
| Treatment | 41 | ||
| Prostate hypertrophy (benign prostatic hyperplasia or hypertrophy; BPH) | 42 | ||
| Definition | 42 | ||
| Aetiopathogenesis | 42 | ||
| Clinical presentation | 42 | ||
| Diagnosis | 42 | ||
| Treatment | 42 | ||
| Testicular cancer | 43 | ||
| Definition | 43 | ||
| Aetiopathogenesis risk factors for testicular cancers | 43 | ||
| Clinical presentation | 44 | ||
| Diagnosis | 44 | ||
| Treatment | 44 | ||
| Older patients | 45 | ||
| Main dental considerations | 45 | ||
| Women’s health | 48 | ||
| Main dental considerations | 48 | ||
| Breast cancer | 48 | ||
| Definition | 48 | ||
| Classification | 48 | ||
| Aetiopathogenesis | 49 | ||
| Clinical presentation | 49 | ||
| Diagnosis | 49 | ||
| Treatment | 49 | ||
| Main dental consideration | 50 | ||
| Cervical cancer | 51 | ||
| Definition | 51 | ||
| Aetiopathogenesis | 51 | ||
| Clinical presentation and classification | 51 | ||
| Diagnosis | 51 | ||
| Treatment | 51 | ||
| Ovarian cancer | 52 | ||
| Definition | 52 | ||
| Aetiopathogenesis | 52 | ||
| Clinical presentation | 52 | ||
| Diagnosis | 52 | ||
| 5 System synopses | 63 | ||
| Main dental considerations in most patients | 63 | ||
| Cardiovascular | 63 | ||
| Main dental considerations | 63 | ||
| Aortic valve disease | 65 | ||
| Aortic stenosis (AS) | 65 | ||
| 6 Trauma | 297 | ||
| Facial trauma | 297 | ||
| Aetiopathogenesis | 297 | ||
| Clinical presentation and classification | 297 | ||
| Diagnosis | 297 | ||
| Treatment | 297 | ||
| Dental considerations | 297 | ||
| Head injury | 300 | ||
| Definition | 300 | ||
| Aetiopathogenesis | 300 | ||
| Clinical presentation and management | 300 | ||
| Head injury sequelae | 302 | ||
| Long-term sequelae | 303 | ||
| Dental considerations | 303 | ||
| Further reading | 303 | ||
| Non-accidental injury (NAI; see also Section 4) | 304 | ||
| Definition | 304 | ||
| Aetiopathogenesis | 304 | ||
| Clinical presentation | 304 | ||
| Diagnosis | 304 | ||
| Management | 304 | ||
| Dental considerations | 305 | ||
| Spinal trauma | 306 | ||
| Diagnosis | 306 | ||
| Treatment | 306 | ||
| Dental considerations | 308 | ||
| 7 Infections | 309 | ||
| A range of infections | 309 | ||
| Aetiopathogenesis | 309 | ||
| Diagnosis | 311 | ||
| Treatment | 311 | ||
| Dental considerations | 311 | ||
| Candidosis (candidiasis) | 313 | ||
| Definition | 313 | ||
| Aetiopathogenesis | 313 | ||
| Clinical presentation and classification | 313 | ||
| Diagnosis | 313 | ||
| Treatment | 313 | ||
| Dental considerations | 313 | ||
| Creutzfeldt–Jakob disease (CJD) | 316 | ||
| Definition | 316 | ||
| Aetiopathogenesis and classification | 316 | ||
| Clinical presentation | 316 | ||
| Diagnosis | 316 | ||
| Treatment | 317 | ||
| Dental considerations | 317 | ||
| Endocarditis (see Cardiovascular disease) | 318 | ||
| Gonorrhoea | 318 | ||
| Definition | 318 | ||
| Aetiopathogenesis | 318 | ||
| Clinical presentation and classification | 318 | ||
| Diagnosis | 318 | ||
| Treatment | 318 | ||
| Dental considerations | 318 | ||
| Healthcare associated infections | 319 | ||
| Main dental considerations | 319 | ||
| Drug resistant infectious agents | 320 | ||
| Surgical wound infections (surgical site infections; SSIs) | 321 | ||
| Aetiopathogenesis | 321 | ||
| Clinical presentation | 322 | ||
| Diagnosis | 322 | ||
| Treatment | 322 | ||
| Central line-associated bloodstream infections (CLABSI) | 322 | ||
| Bites and puncture wounds | 322 | ||
| Bites | 322 | ||
| Puncture wounds | 323 | ||
| Herpes viruses | 325 | ||
| Herpes simplex viruses (HSV) | 325 | ||
| Definition and aetiopathogenesis | 325 | ||
| Clinical presentations | 325 | ||
| 8 Chemical dependence (drug addiction or substance abuse) | 345 | ||
| Chemical dependence | 345 | ||
| Definition | 345 | ||
| Clinical presentation | 345 | ||
| Main dental considerations | 346 | ||
| Alcohol use | 347 | ||
| Diagnosis | 347 | ||
| Treatment | 347 | ||
| 9 Therapeutic modalities | 359 | ||
| Adverse drug reactions | 359 | ||
| Main dental considerations | 359 | ||
| Drug allergies | 359 | ||
| Anaesthetics and related agents | 360 | ||
| Analgesics | 360 | ||
| Antibiotics | 362 | ||
| Radiocontrast media (RCM) reactions | 362 | ||
| Monoclonal antibodies and other biologics (see below) | 363 | ||
| Immunomodulator agents (see below) | 363 | ||
| Drug-induced hypersensitivity syndromes | 363 | ||
| Drug interactions | 363 | ||
| Anti-thrombotic agents | 365 | ||
| Main dental considerations | 365 | ||
| Anticoagulants | 365 | ||
| Heparins | 365 | ||
| Vitamin K antagonists (VKAs) | 367 | ||
| Warfarin | 367 | ||
| Newer oral anticoagulants (NOACs) | 368 | ||
| Antiplatelets | 368 | ||
| Main dental considerations of anti-thrombotic agents | 370 | ||
| Heparins | 371 | ||
| Warfarin and VKAs | 371 | ||
| Novel oral anticoagulants (NOACs) | 372 | ||
| Antiplatelet drugs | 372 | ||
| Other parenteral agents | 372 | ||
| Biological therapies | 373 | ||
| TNF-α inhibitors (anti-TNFs) | 373 | ||
| Lymphocyte modulators and interleukin inhibitors | 373 | ||
| Other biologicals | 376 | ||
| Main dental considerations | 376 | ||
| Chemotherapy (CTx) | 377 | ||
| Central line-associated bloodstream infection (CLABSI) | 380 | ||
| Palmar plantar erythrodysaesthesia (PPE; or hand-foot syndrome) | 380 | ||
| Main dental considerations | 380 | ||
| Complementary and alternative medicine | 381 | ||
| Main dental considerations | 381 | ||
| Graft versus host disease (GVHD) | 382 | ||
| Definition and classification | 382 | ||
| Aetiopathogenesis | 382 | ||
| Clinical presentation | 382 | ||
| Treatment | 382 | ||
| Main dental considerations | 383 | ||
| Haemodialysis | 384 | ||
| Main dental considerations | 386 | ||
| Immunosuppressive treatment | 387 | ||
| Classification | 387 | ||
| Complications | 388 | ||
| Main dental considerations | 388 | ||
| Implanted devices | 389 | ||
| Complications | 389 | ||
| Main dental considerations | 389 | ||
| Comments on specific implants | 389 | ||
| Disruption and complications | 389 | ||
| Osseointegrated dental implants | 394 | ||
| Phakic intraocular lenses | 395 | ||
| Urogynaecologic surgical mesh implants | 395 | ||
| Mucositis | 396 | ||
| Palliative and end of life care | 398 | ||
| Main dental considerations | 402 | ||
| Radiotherapy (RTx) | 403 | ||
| Main dental considerations | 404 | ||
| Splenectomy | 406 | ||
| Aetiopathogenesis | 406 | ||
| Main dental considerations | 406 | ||
| Steroids (corticosteroids) | 407 | ||
| Main dental considerations | 408 | ||
| Transplantation | 409 | ||
| Bone marrow transplantation (BMT; Haematopoietic stem cell transplantation; HSCT) | 410 | ||
| Heart transplantation | 410 | ||
| Liver transplantation | 411 | ||
| Lung transplantation | 411 | ||
| Pancreatic transplantation | 411 | ||
| Renal transplantation | 411 | ||
| Main dental considerations in transplant patients | 411 | ||
| Before transplantation | 412 | ||
| After organ transplantation | 412 | ||
| Further reading | 412 | ||
| 10 Disability, vulnerability and impairment | 413 | ||
| Main dental considerations | 413 | ||
| Bedbound patients | 413 | ||
| Aetiopathogenesis | 413 | ||
| Clinical care | 413 | ||
| Main dental considerations | 414 | ||
| Cerebral palsy (CP) | 415 | ||
| Definition | 415 | ||
| Aetiopathogenesis | 415 | ||
| Clinical presentation and classification | 415 | ||
| Diagnosis | 416 | ||
| Treatment | 416 | ||
| Main dental considerations | 416 | ||
| Clefts | 417 | ||
| Definition | 417 | ||
| Aetiopathogenesis | 417 | ||
| Clinical presentation | 417 | ||
| Diagnosis | 418 | ||
| Treatment and main dental considerations | 418 | ||
| Disability and impairment | 420 | ||
| Definitions | 420 | ||
| Aetiopathogenesis | 420 | ||
| Treatment | 420 | ||
| Main dental considerations | 420 | ||
| Down syndrome (DS) | 422 | ||
| Definition | 422 | ||
| Aetiopathogenesis | 422 | ||
| Clinical presentation | 422 | ||
| Diagnosis | 424 | ||
| Main dental considerations | 424 | ||
| Hearing impairment | 425 | ||
| Main dental considerations | 425 | ||
| Learning disability and impairment | 426 | ||
| Definition | 426 | ||
| Aetiopathogenesis | 426 | ||
| Clinical presentation | 426 | ||
| Classification | 426 | ||
| Diagnosis | 426 | ||
| Treatment | 427 | ||
| Main dental considerations | 427 | ||
| Paralyses (Head and neck) | 427 | ||
| Bulbar palsy | 427 | ||
| Appendix: Normal test values | 439 | ||
| Full blood count (FBC) examines: | 439 | ||
| Index | 447 | ||
| A | 447 | ||
| B | 449 | ||
| C | 450 | ||
| D | 453 | ||
| E | 454 | ||
| F | 455 | ||
| G | 456 | ||
| H | 456 | ||
| I | 458 | ||
| J | 459 | ||
| K | 459 | ||
| L | 459 | ||
| M | 460 | ||
| N | 462 | ||
| O | 462 | ||
| P | 463 | ||
| Q | 465 | ||
| R | 465 | ||
| S | 466 | ||
| T | 467 | ||
| U | 468 | ||
| V | 469 | ||
| W | 469 | ||
| X | 469 |